Document:

exv10w5

EXHIBIT
10.5

SEPARATION AGREEMENT

     This Separation Agreement (this “Agreement”) is entered into between Meg M. McGilley
(“Employee”), and Somaxon Pharmaceuticals, Inc. (the “Company”), as of May 14, 2009 (the “Effective
Date”).

     WHEREAS, the Company and Employee previously entered into that certain Amended and Restated
Employment Agreement dated as of December 1, 2007 (the “Existing Agreement”);

     WHEREAS, the Company and Employee wish to enter into this Agreement for the purpose of
terminating and superseding the Existing Agreement; and

     WHEREAS, the Company and Employee wish to terminate their employment relationship effective as
of May 15, 2009 (the “Termination Date”) and to resolve amicably all of their obligations to each
other, including, without limitation, under the Existing Agreement.

     NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties agree as
follows:

     1. Existing Agreement. As of the Effective Date, the Existing Agreement shall be
superseded entirely by this Agreement, the Existing Agreement shall be terminated and be of no
further force or effect and the Company’s obligations to Employee pursuant to Section 7 of the
Existing Agreement shall be abrogated in all respects.

     2. Employment Status; Consulting Agreement. Effective as of the Termination Date,
Employee’s employment and other service relationships with the Company, including as Vice President
and Chief Financial Officer of the Company (and any other positions he or she may hold with the
Company) shall terminate. As of the Termination Date, Employee will be offered a consulting
arrangement with the Company on substantially the terms attached hereto as Exhibit A.

     3. Compensation.

          (a) Base Salary and Accrued Benefits. On the Termination Date, the Company shall
issue to Employee his or her final paycheck, reflecting (i) his or her earned but unpaid base
salary through the Termination Date and (ii) all accrued, unused vacation or PTO due Employee
through the Termination Date. Except as set forth in Sections 3(b), 3(c) and 4 below, Employee
acknowledges and agrees that with his or her final check, Employee will have received all monies,
bonuses, commissions, expense reimbursements, paid time off or other compensation he or she earned
or was due during his or her employment by the Company, including severance pay.

          (b) Partial Severance. As partial consideration for Employee’s agreement to be bound
by the terms of this Agreement as of the Effective Date, the Company hereby agrees to pay to
Employee the sum of $42,500.00 on the Termination Date, which amount, together with any amount to
be paid pursuant to Section 4(a) below, shall be the exclusive severance benefits to which Employee
is entitled.

          (c) Expense Reimbursements. The Company, within thirty (30) days after the
Termination Date, will reimburse Employee for any and all reasonable and necessary business
expenses incurred by Employee in connection with the performance of his or her job duties prior to
the Termination Date, which expenses shall be submitted to the Company with supporting receipts
and/or documentation no later than twenty-one (21) days after the Termination Date.

 

 

          (d) Benefits. Employee’s entitlement to benefits from the Company, and eligibility to
participate in the Company’s benefit plans, shall cease on the last day of the month of the
Termination Date, except to the extent Employee elects to and is eligible to receive continued
healthcare coverage pursuant to the provisions of the Consolidated Omnibus Budget Reconciliation
Act of 1985, as amended (“COBRA”), for himself or herself and any covered dependents, at his or her
sole expense in accordance with the provisions of COBRA.

          (e) Stock Awards.

               (i) As of the Termination Date, Employee has been granted the stock options, restricted stock
and restricted stock units listed on Exhibit B attached hereto. Employee’s stock awards
shall continue to be governed in accordance with and subject to the terms of the stock option
agreements and the related plan pursuant to which they were granted. Employee’s vested stock
options will remain exercisable for one hundred eighty (180) days after the date on which
Employee’s services to the Company (whether as an employee or as a consultant) terminate in
accordance with the terms of the stock option agreements and the related plan pursuant to which
they were granted.

               (ii) Notwithstanding any provision to the contrary in Employee’s options under the Company’s
2005 Equity Incentive Award Plan (the “Option Plan”) or other plan (including, without limitation,
the expiration dates or vesting provisions thereof) or any restricted stock agreement, (1) the
unvested portion, if any, of Employee’s outstanding options and restricted stock units shall be
deemed to have vested on the Termination Date with respect to the number of shares that would have
vested had Employee remained employed by the Company for twelve (12) months following such
termination, and (2) any restrictions with respect to any restricted shares of the Company’s
capital stock that Employee then holds shall immediately lapse with respect to the number of
restricted shares that would have vested had Employee remained employed by the Company for twelve
(12) months following such termination; provided, however, that this Section 3(e)(ii) shall not
apply to the shares of restricted stock granted to Employee on October 8, 2007 or the stock options
granted to Employee on February 17, 2009. Employee’s vested and unvested stock awards after giving
effect to this Section 3(e)(ii), are reflected on Exhibit B.

     4. Future Cash Payment.

          (a) As partial consideration for Employee’s agreement to be bound by the terms of this
Agreement as of the Effective Date, and subject to Sections 4(b) and 4(c) below, the Company hereby
agrees to pay to Employee the sum of $246,412.50 on December 31, 2010, provided that if any of the
following events occurs prior to such date, such amount will be payable to Employee upon the date
of such event (each, an “Acceleration Event”): (i) a Qualified Financing, (ii) a Change in Control
(as such term is defined in the Option Plan) (other than a Change in Control that results from the
consummation of a financing or strategic collaboration transaction, or a series of such
transactions, that results in working capital for the Company of less than $10 million), or (iii)
the Company files a petition in bankruptcy, applies for or consents to the appointment of a
receiver or trustee, makes an assignment for the benefit of its creditors or suffers or permits the
entry of any order adjudicating it to be bankrupt or insolvent and such order is not discharged
within sixty (60) days, or the Company’s Board of Directors otherwise approves a liquidation or
dissolution of the Company. The foregoing amount, together with the amount paid pursuant to
Section 3(b) above, shall be the exclusive severance benefits to which Employee is entitled. For
purposes of this Agreement, a “Qualified Financing” means the consummation of a financing or
strategic collaboration transaction, or the last in a series of such transactions, resulting in
working capital for the Company of at least $10 million in the aggregate.

2

 

          (b) Employee’s right to receive the payment described in Section 4(a) above shall be
contingent on Employee providing to the Company (and failing to revoke) a general release in the
form attached hereto as Exhibit C (the “
Release ”). Employee shall have twenty-one
(21) days following the earlier of December 31, 2010 or the date of an Acceleration Event to
execute such Release. It is understood that, in the event that Employee is at least forty (40)
years old on the date of the termination of his or her employment with the Company, Employee has a
certain period to consider whether to execute such Release, and Employee may revoke such Release
within seven (7) days after execution. In the event Employee does not execute such Release within
the applicable period, or if Employee revokes such Release within the subsequent seven (7) day
period, Employee shall not be entitled to the aforesaid payments and benefits. The date on which
Employee’s Release becomes effective and the applicable revocation period lapses shall be the
“Release Effective Date.”

          (c) The payment described in Section 4(a) above shall be paid within five (5) days following
the Employee’s Release Effective Date.

          (d) Notwithstanding the foregoing or anything to the contrary contained in this Agreement, in
the event that Employee is re-hired by the Company on a full-time basis prior to the payment of the
amount set forth in Section 4(a) above, this Section 4 shall immediately terminate and be of no
further force and effect as of the date of commencement of such full-time employment, and such
amount shall no longer be payable.

     5. Proprietary Information. Employee acknowledges that he or she continues to be
bound by the Proprietary Information and Inventions Agreement (the “Confidential Information
Agreement”) that he or she signed in connection with his or her employment, in accordance with the
terms thereof.

     6. Return of Equipment. Within five (5) days of the Termination Date, Employee shall
return to the Company in good working order any equipment, instruments, or accessories of the
Company in his or her custody for the purpose of conducting the business of the Company without
deleting, removing, or duplicating any data reflecting the Company’s proprietary information, or if
not returned, account to the Company to its reasonable satisfaction for all such equipment,
instruments, or accessories.

     7. Miscellaneous.

          (a) Entire Agreement, Amendments. This Agreement, together with the Exhibits hereto
and the documents referred to herein and therein, sets forth the entire understanding and agreement
of the parties with respect to the subject matter hereof and supersedes all prior oral and written
understandings and agreements, including, without limitation, the Existing Agreement. There are no
representations, agreements, arrangements or understandings, oral or written, among the parties
relating to the subject matter hereof which are not expressly set forth herein, and no party hereto
has been induced to enter into this Agreement, except by the agreements expressly contained herein.

          (b) Amendments. No amendment or modification of this Agreement shall be effective
unless set forth in a writing signed by the Company and Employee.

          (c) Successors and Assigns. This Agreement shall inure to the benefit of and be
enforceable by Employee and Employee’s heirs, executors, administrators and legal representatives,
and by the Company and its successors and assigns. This Agreement and all rights hereunder are
personal to Employee and shall not be assignable.

3

 

          (d) Severability. If any provision of this Agreement or the application thereof is
held invalid, the invalidity shall not affect the other provisions or application of this Agreement
that can be given effect without the invalid provisions or application, and to this end the
provisions of this Agreement are declared to be severable.

          (e) Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of California without reference to principles of conflict of laws.

          (f) Taxes. All payments required to be made to Employee hereunder, whether during the
term of Employee’s employment hereunder or otherwise, shall be subject to all applicable federal,
state and local tax withholding laws. Employee acknowledges and agrees that neither the Company
nor the Company’s counsel has provided any tax advice to Employee and that Employee is free to
consult with a tax advisor of his or her choosing.

          (g) Headings. The headings set forth herein are included solely for the purpose of
identification and shall not be used for the purpose of construing the meaning of the provisions of
this Agreement.

          (h) Arbitration. Any dispute or controversy between Company and Employee, arising out
of or relating to this Agreement, the breach of this Agreement, or otherwise, shall be settled by
arbitration in San Diego, California administered by the American Arbitration Association in
accordance with its National Rules for the Resolution of Employment Disputes then in effect and
judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction
thereof. The arbitrator shall have the authority to award any remedy or relief that a court of
competent jurisdiction could order or grant, including, without limitation, the issuance of an
injunction. However, either party may, without inconsistency with this arbitration provision,
apply to any court having jurisdiction over such dispute or controversy and seek interim
provisional, injunctive or other equitable relief until the arbitration award is rendered or the
controversy is otherwise resolved. Except as necessary in court proceedings to enforce this
arbitration provision or an award rendered hereunder, or to obtain interim relief, neither a party
nor an arbitrator may disclose the existence, content or results of any arbitration hereunder
without the prior written consent of Company and Employee. The Company shall pay all of the direct
costs and expenses in any arbitration hereunder and the arbitrator’s fees and costs; provided,
however, that the arbitrator shall have the discretion to award the prevailing party reimbursement
of its, his or her reasonable attorney’s fees and costs. The Company and Employee hereby expressly
waive their right to a jury trial.

          (i) Construction. Each party has cooperated in the drafting and preparation of this
Agreement. Therefore, in any construction to be made of this Agreement, the same shall not be
construed against any party on the basis that the party was the drafter.

          (j) Section 409A of the Code. This Agreement is not intended to provide for any
deferral of compensation subject to Section 409A of the Code. To the extent applicable, this
Agreement shall be interpreted in accordance with Code Section 409A and Department of Treasury
regulations and other interpretive guidance issued thereunder.

          (k) RIGHT TO ADVICE OF COUNSEL. EMPLOYEE ACKNOWLEDGES THAT HE HAS THE RIGHT, AND
IS ENCOURAGED, TO CONSULT WITH HIS OR HER LAWYER; BY HIS OR HER SIGNATURE BELOW, EMPLOYEE

4

 

ACKNOWLEDGES THAT HE HAS CONSULTED WITH HIS OR HER LAWYER CONCERNING THIS AGREEMENT.

(Signature Page Follows)

5

 

     In Witness Whereof, the parties have executed this Agreement as of the date
first above written.

	 	 	 	 	 
	 	

COMPANY:

Somaxon Pharmaceuticals, Inc.

 	 
	 	By:  	/s/ Jeffrey W. Raser
 	 
	 	 	Name:  	Jeffrey W. Raser  	 
	 	 	Title:  	SVP 	 
	 
	 	Employee:

 	 
	 	/s/ Meg. M. McGilley
 	 
	 	Meg M. McGilley 	 
	 	 	 

SIGNATURE PAGE TO SEPARATION AGREEMENT

 

 

	 	 	 	 	 

EXHIBIT A

FORM OF CONSULTING AGREEMENT

[Attached]

 

 

EXHIBIT B

SCHEDULE OF STOCK AWARDS

[Attached]

 

 

EXHIBIT C

GENERAL RELEASE OF CLAIMS

	 	 
	 	[The language in this Release may change based on legal developments and evolving best practices;

this form is provided as an example of what will be included in the final Release document.]
 

     Certain capitalized terms used in this Release are defined in the Separation Agreement by and
between Somaxon Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Meg M.
McGilley (“Employee”) dated as of the 14th day of May, 2009 (the “Agreement”), which Employee has
previously executed and of which this Release is a part.

     Pursuant to the Agreement, and in consideration of and as a condition precedent to the payment
to be provided under Section 4(a) of the Agreement, Employee hereby furnishes the Company with this
Release.

     Employee hereby confirms his/her obligations under the Company’s Confidential Information
Agreement.

     On Employee’s own behalf and on behalf of Employee’s heirs, estate and beneficiaries, Employee
hereby waives, releases, acquits and forever discharges the Company, and each of its Subsidiaries
and affiliates, and each of their respective past or present officers, directors, agents, servants,
employees, shareholders, predecessors, successors and assigns, and all persons acting by, through,
under, or in concert with them, or any of them, of and from any and all suits, debts, liens,
contracts, agreements, promises, claims, liabilities, demands, causes of action, costs, expenses,
attorneys’ fees, damages, indemnities and obligations of every kind and nature, in law, equity, or
otherwise, known and unknown, fixed or contingent, suspected and unsuspected, disclosed and
undisclosed (“Claims”), from the beginning of time to the date hereof, including without
limitation, Claims that arose as a consequence of Employee’s employment with the Company, or
arising out of the termination of such employment relationship, or arising out of any act committed
or omitted during or after the existence of such employment relationship, or based upon or arising
from the Existing Agreement, or based upon or arising from the Company’s non-performance of its
obligations under the Existing Agreement, all up through and including the date on which this
Release is executed, including, but not limited to, Claims which were, could have been, or could be
the subject of an administrative or judicial proceeding filed by Employee or on Employee’s behalf
under federal, state or local law, whether by statute, regulation, in contract or tort. This
Release includes, but is not limited to: (1) Claims for intentional and negligent infliction of
emotional distress; (2) tort Claims for personal injury; (3) Claims or demands related to salary,
bonuses, commissions, stock, stock options, or any other ownership interest in the Company,
vacation pay, fringe benefits, expense reimbursements, severance pay, front pay, back pay or any
other form of compensation; (4) Claims for breach of contract; (5) Claims for any form of
retaliation, harassment, or discrimination; (6) Claims pursuant to any federal, state or local law
or cause of action including, but not limited to, the federal Civil Rights Act of 1964, as amended,
the federal Age Discrimination in Employment Act of 1967, as amended (“ADEA”), the federal Employee
Retirement Income Security Act of 1974, as amended, the federal Americans with Disabilities Act of
1990, the California Fair Employment and Housing Act, as amended, and the California Labor Code;
and (7) all other Claims based on tort law, contract law, statutory law, common law, wrongful
discharge, constructive discharge, fraud, defamation, emotional distress, pain and suffering,
breach of the implied covenant of good faith and fair dealing, compensatory or punitive damages,
interest, attorneys’ fees, and reinstatement or re-employment. If any court rules that Employee’s
waiver of the right to file any administrative or judicial charges or complaints is ineffective,
Employee agrees not to seek or accept any money damages or any other relief upon the filing of any
such administrative or judicial charges or complaints.

 

 

     Employee acknowledges that he/she has read and understand Section 1542 of the California Civil
Code which reads as follows: “A general release does not extend to claims which the creditor does
not know or suspect to exist in his or her favor at the time of executing the release, which if
known by him or her must have materially affected his or her settlement with the debtor.” Employee
hereby expressly waives and relinquishes all rights and benefits under that section and any law of
any jurisdiction of similar effect with respect to his/her release of any unknown Claims Employee
may have against the Company.

     Notwithstanding the foregoing, nothing in this Release shall constitute a release by Employee
of any claims or damages based on any right Employee may have to enforce the Company’s
executory obligations under the Agreement, any right Employee may have to vested or earned
compensation and benefits, or Employee’s eligibility for indemnification under applicable law,
Company governance documents, Employee’s indemnification agreement with the Company or under any
applicable insurance policy with respect to Employee’s liability as an employee or officer of the
Company.

     If Employee is forty (40) years of age or older at the time of the termination, Employee
acknowledges that he/she is knowingly and voluntarily waiving and releasing any rights he/she may
have under ADEA. Employee also acknowledges that the consideration given under the Agreement for
the Release is in addition to anything of value to which he/she was already entitled. Employee
further acknowledges that he/she has been advised by this writing, as required by the ADEA, that:
(A) his/her waiver and release do not apply to any rights or claims that may arise on or after the
date he/she executes this Release; (B) Employee has the right to consult with an attorney prior to
executing this Release; (C) Employee has twenty-one (21) days following the earlier of December 31,
2010 or the date of an Acceleration Event to consider this Release (although he/she may choose to
voluntarily execute this Release earlier); (D) Employee has seven (7) days following the execution
of this Release to revoke the Release; and (E) this Release shall not be effective until the date
upon which the revocation period has expired, which shall be the eighth (8th) day after
this Release is executed by Employee, without Employee’s having given notice of revocation.

     Employee further acknowledges that Employee has carefully read this Release, and knows and
understands its contents and its binding legal effect. Employee acknowledges that by signing this
Release, Employee does so of Employee’s own free will, and that it is Employee’s intention that
Employee be legally bound by its terms. Employee further acknowledges that if Employee does not
sign this release within twenty-one (21) days following the earlier of December 31, 2010 or the
date of an Acceleration Event, or revokes this Release within the foregoing revocation period, if
applicable, Employee shall not be entitled to the payments and benefits provided under Section 4(a)
of the Agreement.

	 	 	 	 	 
	 	 	 
	 	  	

 	 
	 	Meg M. McGilley   	 
	 
	 	Date:exv10w1

Exhibit 10.1

EXECUTION COPY

FIRST AMENDMENT TO AMENDED AND RESTATED LOAN AGREEMENT

     FIRST AMENDMENT, dated as of December 31, 2003 (this “Amendment”), to the AMENDED AND RESTATED
LOAN AGREEMENT, dated as of August 13, 2002 (as previously amended, supplemented or modified, the
“Existing Agreement”; and as amended by this Amendment, the “Agreement”), among FURMANITE LIMITED
(formerly named FURMANITE PLC formerly named KANEB UK PLC), a company incorporated under the laws
of England and Wales (registered number 2530049) (the “Borrower”), FURMANITE WORLDWIDE, INC., a
Delaware corporation (“Holding”), and BANK OF SCOTLAND, as agent (in such capacity, the “Agent”)
for the Banks (in such capacity, the “Agent”).

W I T N E S S E T H:

          WHEREAS, for the purpose of facilitating a final dividend by FIL to Furmanite 1986
(“Furmanite”) and an interim dividend by Furmanite to the Borrower, the parties wish to amend the
Existing Agreement to permit (a) an unsecured £5,500,000.00 loan by XANSER FINANCIAL LLC, a
Delaware limited liability company, to FIL and a (b) an unsecured £5,500,000.00 loan by the
Borrower to XANSER SERVICES LLC, a Delaware limited liability company;

          NOW, THEREFORE, it is agreed:

          Section 1. Definitions. Terms used in this Amendment which are defined in the
Existing Agreement shall have the meanings specified therein (unless otherwise defined herein)
and shall include in the singular number the plural and in the plural number the singular.

          Section 2. Amendments. Upon the Amendment Effective Date (as defined in Section 3 below):

          2.1 Other Indebtedness. Section 8.3 of the Existing Agreement is amended by adding
the following Section 8.3(xiv):

	 	 	“(xiv) 	 an unsecured £5,500,000.00 loan (the “Xanser Financial Loan”) by XANSER
FINANCIAL LLC, a Delaware limited liability company (“Xanser Financial”), to
FIL pursuant to an Unsecured Term Loan Agreement dated December 31, 2003,
between FIL and Xanser Financial (the “Xanser Financial Loan
Agreement”), but only if (a) the Xanser Financial Loan is used solely by
FIL to pay to Furmanite a final dividend of £5,500,000.00 declared on December
31, 2003 for its financial year ended December 31, 2002 (the “FIL Dividend”),
(b) the FIL Dividend is used by Furmanite solely to pay to the Borrower an
interim dividend of £5,500,000.00 declared on December 31, 2003 in respect of
the financial year ended December 31, 2002 (the “Furmanite Dividend”), (c) the
Furmanite Dividend is used by the Borrower solely to make the Xanser Services
Loan (as defined below) and (d) Xanser Financial has executed and delivered to
the Agent a subordination agreement substantially in the

1

 

	 	 	 	form of the XANSER Subordination Agreement and satisfactory to the Agent in
its sole discretion.”

          2.2
Advances and Loans. Section 8.5 of the Existing Agreement is amended by inserting
at the end thereof the following the following paragraph:

          “Notwithstanding any other provisions in this Agreement, the Borrower may use
the Furmanite Dividend to make an unsecured £5,500,000.00 loan (the “Xanser Services
Loan”) to XANSER SERVICES LLC, a Delaware limited liability company (“Xanser
Services”), pursuant to a loan agreement substantially in the form of the Xanser
Financial Loan Agreement and satisfactory to the Agent in its sole discretion (the
“Xanser Services Loan Agreement”), but only if the Xanser Services Loan is
pledged to the Banks pursuant to the Borrower Pledge Agreement.”

          2.3
Related Transactions. Section 8.11(b) of the Existing Agreement is amended by
deleting Section 8.11(b) in its entirety and substituting, in lieu thereof, the following:

          “(b) No Loan Party will make any payments, directly or indirectly, to XANSER
or any officer of director of XANSER, except as permitted by the XANSER Management
Agreement, Section 8.5, Section 8.11(a) or Section 8.15.”

          Section
3. Conditions Precedent.

          The amendments provided for by this Amendment shall become effective on the date (the
“Amendment Effective Date”) on which the following conditions precedent shall be satisfied
to the satisfaction of the Agent or waived:

          3.1
Default, etc. On the Amendment Effective Date, there shall exist no Event of
Default and all representations and warranties made by the Borrower or Holding in the Existing
Agreement or in the other Loan Documents or otherwise made by the Borrower or Holding in
writing in connection herewith or therewith shall be true and correct in all material respects
with the same effect as though such representations and warranties have been made at and as of such
time except to the extent such representations and warranties were made only as of a specific date.

          3.2 Documents. On the Amendment Effective Date, the Agent shall have
received this Amendment executed and delivered by each of the parties hereto.

          3.3 Approvals and Consents. All orders, permissions, consents, approvals,
licenses, authorizations and validations of, and filings, recordings and registrations with,
and exemptions by, any Government Authority, or any other Person, required to authorize or
required in connection with the execution, delivery and performance of this Amendment and the
transactions contemplated hereby by either of the Borrower or Holding shall have been obtained
(and, if so requested, furnished to the Agent).

          Section 4. Agreement in Full Force and Effect as Amended. Except as specifically
amended hereby, all of the terms and conditions of the Agreement shall remain in

2

 

full force and effect. All references to the “Agreement” in any other Loan Document or other document
or instrument shall be deemed to mean the Agreement as amended by this Amendment. This Amendment
shall not constitute a novation of the Agreement, but shall constitute an amendment thereof.

          Section 5. Counterparts. This Amendment may be executed in any number of counterparts
and by separate parties hereto on separate counterparts, each of which when executed shall be
deemed an original, but all such counterparts taken together shall constitute one and the same
instrument.

          Section 6. Governing Law. THIS AMENDMENT SHALL BE GOVERNED
BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF
THE STATE OF NEW YORK.

          IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and
delivered by their respective duly authorized officers as of the date first above written.

	 	 	 	 	 	 	 
	 	 	FURMANITE LIMITED
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Howard C. Wadsworth	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Howard C. Wadsworth
	 	 	Title:   Director
	 
	 	 	 	 	 	 
	 	 	FUMANITE WORLDWIDE, INC
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Howard C. Wadsworth	 	 
	 

	 	 	 	 	 	 
	 	 	Name: Howard C. Wadsworth
	 	 	Title:  Vice President
	 
	 	 	 	 	 	 
	 	 	BANK OF SCOTLAND, individually and as Agent
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 	 	 
	 	 	Name:
	 	 	Title:

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]